PBI-05204

· MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PBI-05204, covering 2016-02-19 to 2016-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma [Phase 2]